“…Potential mechanisms underlying these actions include a ) inhibition of neutrophil function and platelet activation ( 43,44 ), b ) serving as partial agonists for PPAR ␥ ( 14,15,(45)(46)(47), c ) inhibition of cytokine expression via inhibition of DNA binding by the p65 unit of NF-B ( 48 ), and d ) upregulation of phase 2 gene expression via Keap1/Nrf2-dependent ( 5,49,50 ) and -independent mechanisms ( 51 ). Critical pro-infl ammatory enzymatic activities are also inhibited by fatty acid nitroalkenes, including xanthine oxidoreductase and cyclooxygenase-2 ( 52,53 ). These actions result in antiinfl ammatory responses in diverse animal models of disease including limiting restenosis after vessel injury ( 54 ), attenuation of weight gain and loss of insulin sensitivity in murine models of metabolic syndrome ( 6, 55 ), inhibition of sepsis-induced renal failure ( 56 ), prevention of ischemia-reperfusion injury ( 31,32,57 ), reduction of plaque formation in a murine ApoE Ϫ / Ϫ atherosclerosis model, and the reduction of chemically-induced infl ammatory bowel disease ( 47 ).…”